Dr. Hobein (Nachf.) GmbH develops, manufactures and distributes medical skin care, skin cleansing and dermocosmetic products as well as chemical-pharmaceutical products under the EUBOS brand. The company is owner-managed (two family members and an external managing director) and carries out all development and production exclusively in Germany. Domestic distribution is exclusively through pharmacies, the pharmaceutical wholesale and pharmacy mail-order; internationally the company cooperates with national trading partners. The product range specifically targets skin needs such as sensitive, dry and reddened skin as well as diabetic skin, dry children's skin and skin affected by rosacea and is dermatologically validated.
die Herstellung und der Vertrieb von medizinischen Hautpflege-, Hautreinigungs-, dermokosmetischen Produkten sowie von chemisch - pharmazeutischen Produkten im weiteren Sinne.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Bonn Local Court, HRB 10719 (as of 31 October 2026)
| Name | Type | City |
|---|---|---|
| Verena Janssen | Geschäftsführer(in) | Bonn |
| Ralf Voigt | Geschäftsführer(in) | Köln |
| Britta Wilcke-Janßen | Geschäftsführer(in) | Bonn |
Source: German Commercial Register (Handelsregister) Bonn Local Court, HRB 10719 (as of 31 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €17,954,551 | -€51,070 | €17,261,925 | — |
| 2023 | €18,600,146 | -€19,224 | €17,328,854 | — |
| 2022 | €20,695,632 | €429,225 | €17,523,566 | — |
| 2021 | €22,661,836 | €1,424,369 | €17,416,346 | — |
| 2020 | €23,076,792 | €1,229,722 | €16,111,520 | — |
| 2019 | €23,144,293 | €1,172,219 | €17,938,564 | — |
| 2018 | Rohergebnis€19.4M2 | €2,409,904 | €17,235,068 | — |
| 2017 | Rohergebnis€21.3M2 | €4,222,875 | €16,345,151 | — |
| 2016 | Rohergebnis€20.4M2 | €3,918,519 | €12,388,483 | — |
| 2015 | Rohergebnis€21.9M2 | €4,965,419 | €15,878,450 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Bonn Local Court, HRB 10719 (as of 31 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €5,373,436 | 99.5% |
| Depreciation | €5,799 | 0.1% |
| Interest & Similar | €19,167 | 0.4% |
